ELVElevance Health
$403.51-0.98%Real quote · delayedHealth insurance🏛️ Company factsSEC filings + FINRA official data
Annual revenue $199.1B · latest quarter up 1.4% YoY · profitable (FY net income $5.7B) · short activity above its recent average — bears adding.
FY revenue
$199.1B
2025-12
Latest Q YoY
+1.4%
FY net income
$5.7B
Diluted EPS
$25.28
Short volume
75.7%
20d avg 59.3% · shorts building
🐋 5%+ ownership filings (last 180d)
The parties below hold over 5% of this company and disclosed it to the SEC (mandatory in US markets). "Activist" filers state an intent to influence the company; "Passive" are pure investment positions.
- 2026-04-29passive (13G)VANGUARD CAPITAL MANAGEMENT LLC
- 2026-03-26passive (13G)VANGUARD GROUP INC
🎯 Market expectations
Expectation reliability High · 86/100Nasdaq analyst consensus · the pre-news baseline
- Jun 2026$7.45 vs $6.18+20.55%
- Mar 2026$12.58 vs $10.68+17.79%
- Dec 2025$3.33 vs $3.10+7.42%
- Sep 2025$6.03 vs $4.98+21.08%
The takeaway
This company habitually beats by +16.7% — the next report has to clear that bar to count as good news.
Analyst estimates, not our forecast · not investment advice
What's moving this stock lately
0 direct · 1 2nd-order · 0 thematicRanked by impact strength · strength = estimated move × freshness decay (shorter-lived effects decay faster)
- #1▲0.36%2nd-orderBillionaire Bill Ackman Sells Alphabet Stock and Buys a Mega-Cap Stock Down 42% From Its High1d ago
As a fellow managed-care insurer, it benefits from broader sector sentiment improvement.
Also named: GOOGL · GOOG · UNH · HUM · CI
🕰️ Price × news · engine report card
Drag to pan, scroll to zoom · real daily bars and volume
📜 Call history (newest first
13 engine calls on this stock — each with direction, magnitude and its verified outcome · sign up to view
Sign up · free 7-day trial →Impact chains · crowding · conviction engine · insider signals — free 7-day trial on signup.
Sign up · free 7-day trial →